Thorne Healthtech P/E Ratio

Thorne Healthtech (THRN) currently reports a P/E ratio of 33.97. That is below the Consumer Discretionary sector average of 38.05. Use the charts on this page to explore Thorne Healthtech's P/E ratio history and peer comparisons.

Thorne Healthtech's P/E ratio of 33.97 is lower than the Consumer Discretionary sector average of 38.05. That is roughly 10.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Thorne Healthtech's market price to a fundamental measure such as earnings, sales, or book value. At 33.97, THRN can look expensive or cheap only in context — versus its own history, growth rate, and Consumer Discretionary peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 33.97, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Discretionary average is 38.05. From there, open related valuation or income-statement pages for Thorne Healthtech, and consider following THRN for alerts when major investors trade the stock.

Thorne Healthtech is classified in the Consumer Discretionary sector. On P/E ratio, it currently shows 33.97 versus a sector average near 38.05. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing THRN with unrelated industries.